Canada markets closed

Bright Minds Biosciences Inc. (DRUG.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
1.3700+0.0700 (+5.38%)
At close: 02:04PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 6.12M
Enterprise Value -591.76k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.01
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3-65.75%
S&P500 52-Week Change 322.38%
52 Week High 38.5800
52 Week Low 31.2900
50-Day Moving Average 31.7760
200-Day Moving Average 32.3096

Share Statistics

Avg Vol (3 month) 31.16k
Avg Vol (10 day) 35.85k
Shares Outstanding 54.46M
Implied Shares Outstanding 64.73M
Float 83.18M
% Held by Insiders 135.72%
% Held by Institutions 15.15%
Shares Short (Apr 15, 2024) 4134
Short Ratio (Apr 15, 2024) 40.25
Short % of Float (Apr 15, 2024) 40.00%
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Mar 15, 2024) 4558

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jul 14, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.52%
Return on Equity (ttm)-79.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.72M
Diluted EPS (ttm)-1.7700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.76M
Total Cash Per Share (mrq)1.51
Total Debt (mrq)54.56k
Total Debt/Equity (mrq)0.90%
Current Ratio (mrq)8.01
Book Value Per Share (mrq)1.35

Cash Flow Statement

Operating Cash Flow (ttm)-5.18M
Levered Free Cash Flow (ttm)-2.66M